UBS

A trio of rare names made use of the attractive issuance conditions and strong appetite for credit to launch debut deals this week. Two of the borrowers — Illimity and Groupama — chose to print subordinated deals into this stable market, while Erste Bank Croatia sold its first public deal outside its home market.

UBS has appointed global heads of equity capital markets for the first time in almost two years as the Swiss bank eyes opportunities in a booming IPO market.

UniCredit took a large chunk of its additional tier one (AT1) funding off the table ahead of the summer break with the sale of a €750m note on Wednesday.

Two infrequent names ventured into the euro market to print debut deals in subordinated formats on Wednesday. Italy's Ilimity bank raised €200m with its first tier two, while French insurer Groupama scooped €500m with its inaugural tier three bond.

Medlive Technology and Brii Biosciences are tapping investors for a combined HK$6.7bn ($863m).

Chinese ride-hailing giant Didi has raised $4.4bn from its New York Stock Exchange IPO, increasing the size of the float after investors pumped more than $40bn of orders into the book.

The Republic of the Philippines focused on investors keen to buy long-dated bonds by selling a dual tranche dollar deal this week. The $3bn trade featured a chunky $2.25bn 25 year portion that easily trumped the sovereign's last similar outing.

Logan Group Co used the last of its offshore debt issuance quota to price a $300m green bond on Monday.

Speculative grade Italian lender Illimity is getting ready to issue its first tier two bond, having mandated leads on Monday to arrange a sub-benchmark subordinated deal.

SCE Intelligent Commercial Management has raised HK$1.85bn ($238.3m) after pricing its IPO at the bottom of the guidance range.

Shui On Land became the first Chinese corporate borrower to sell a sustainability-linked bond (SLB) this week — a move that worked to its advantage.

Chinese ride-hailing firm Didi Chuxing has launched its New York Stock Exchange IPO, aiming to raise $4.03bn from the largest China-into-US listing since Alibaba Group Holding’s jumbo $25bn deal in 2014.